Current Status of Growth Factor Use in Children

Session Date
Session Date: 
January 12, 2021
Didactic
Didactic: 
Beth Carter, MD
At the end of this activity, participants will be able to
At the end of this activity, participants will be able to: 
  1. Summarize overall outcomes in children with GLP-2
  2. Outline the approach to use of GLp-2 analogs in children with SBS-IF
  3. Discuss real-world experience with GLP-2 use in pediatric patients with SBS-IF